H2AX and B-cell non-Hodgkin lymphoma: Furthermore, H2AFX polymorphisms were associated with protection against DLBCL in a Korean population [13] supporting the suggestion that the influence of H2AFX variants may extend to a variety of B-cell lymphoma subtypes.